The pharmaceutical landscape is experiencing a development with the arrival of GLP-1 transdermal systems . These innovative formulations offer a possible alternative to administering glucagon-like peptide-1 https://izaakcgrs707354.glifeblog.com/39605709/glp-1-patches-a-revolutionary-way-to-control-blood-sugar